Rare diseases
Investigational molecules
Locations
6027 Edgewood Bend Court, 92130-8235, United States
Research activity in major depressive disorder includes adjunctive treatment strategies aimed at improving depressive symptoms, maintaining response over time, and evaluating longer-term tolerability in adults with persistent mood symptoms.
The sponsor’s work in this area centers on treatment-resistant and recurrent depression, with emphasis on symptom control and sustained clinical benefit.
Neurocrine Biosciences Inc. runs clinical trials in conditions such as Schizophrenia, Major depression, Adrenogenital syndrome, Tardive dyskinesia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BulgariaBulgariaBulgariaBulgaria
BelgiumBulgariaBelgiumBulgaria
Croatia
AustriaBulgariaBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
